Skip to main content
. 2022 Jul 7;148(9):830–837. doi: 10.1001/jamaoto.2022.1573

Table 3. Quality-of-Life Metrics Related to Smell Loss by Study Arm and Study Assessment Using the Questionnaire for Olfactory Disorders.

Assessmenta Assessment time point Theophylline arm (n = 26) Placebo arm (n = 25)
No. Median score (range) No. Median score (range)
Quality of life Baseline 24 17.39 (6.27 to 26.22) 25 15.96 (5.13 to 30.21)
3 weeks 23 15.39 (3.99 to 25.65) 23 12.54 (3.99 to 27.93)
6 weeks 22 15.39 (4.56 to 25.65) 23 14.25 (2.28 to 26.79)
Baseline to 6 weeks’ change, median difference (95% CI) 22 0.86 (−0.57 to 2.85) 23 1.43 (−0.29 to 3.14)
Quality of life-negative statements Baseline 24 26.50 (10.00 to 42.00) 25 22.00 (8.00 to 48.00)
3 weeks 23 25.00 (6.00 to 40.00) 23 20.00 (5.00 to 43.00)
6 weeks 22 25.00 (6.00 to 40.00) 23 22.00 (2.00 to 43.00)
Baseline to 6 weeks’ change, median difference (95% CI) 22 1.50 (−1.00 to 4.50) 23 1.80 (−1.00 to 5.00)
Parosmia Baseline 24 1.08 (0.36 to 1.44) 25 1.32 (0.00 to 1.44)
3 weeks 23 0.96 (0.00 to 1.44) 23 0.96 (0.00 to 1.44)
6 weeks 22 1.20 (0.24 to 1.44) 23 1.08 (0.24 to 1.44)
Baseline to 6 weeks’ change, median difference (95% CI) 22 −0.06 (−0.18 to 0.06) 23 0.06 (−0.60 to 0.24)
Sincerity Baseline 24 1.44 (0.36 to 2.70) 25 1.08 (0.18 to 2.52)
3 weeks 23 1.26 (0.18 to 2.70) 23 1.44 (0.00 to 3.24)
6 weeks 22 1.44 (0.54 to 2.34) 23 1.26 (0.36 to 2.70)
Baseline to 6 weeks’ change, median difference (95% CI) 22 0.00 (−0.09 to 0.18) 23 −0.14 (−0.36 to 0.00)
a

Higher scores for quality of life, quality of life-negative statements, and parosmia indicate a higher degree of impairment. Lower scores for sincerity suggest a greater tendency to give socially desirable answers.